We are live on
!
Find out more
RM
RP Management Portfolio holdings
AUM
$139M
1-Year Est. Return
37.98%
This Fund
S&P 500
This Quarter
Est. Return
+22.74%
1 Year Est. Return
-37.98%
3 Year Est. Return
+207.8%
5 Year Est. Return
+1,098.05%
10 Year Est. Return
–
AUM
$184M
AUM Growth
-$60.5M
(-25%)
Cap. Flow
-$102M
Cap. Flow
% of AUM
-55.15%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$81.2M |
| 2 |
Cytokinetics
CYTK
|
+$20.4M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $108M | 58.6% |
1,111,111
-1,000,000
| -47% | -$81.2M |
|
|
EPZM
2
DELISTED
Epizyme, Inc
EPZM
| $76.2M | 41.38% |
9,166,667
| – | – |
|
|
VIRX
3
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $42K | 0.02% |
3,700
| – | – |
|
|
4
Cytokinetics
CYTK
$11.5B
| – | – |
-875,656
| Closed | -$20.4M |
|
Similar funds
PC
LA
TP
SC
MFG
MADFP
RM
NC